Tissue transglutaminase IgA (tTG-IgA) is an autoantibody directed against the enzyme transglutaminase 2, which is the primary autoantigen in celiac disease. It is the first-line serological test recommended for celiac disease screening due to its high sensitivity (>90%) and specificity (>95%) in IgA-sufficient individuals. Elevated levels strongly correlate with intestinal villous atrophy and serve as both a diagnostic and monitoring marker. Transglutaminase 2 (TG2) is a ubiquitous enzyme involved in cross-linking proteins, including deamidation of gliadin peptides derived from dietary gluten, which enhances their immunogenicity in genetically susceptible individuals (HLA-DQ2/DQ8). In celiac disease, immune activation against TG2 leads to IgA autoantibody production, intestinal inflammation, and progressive villous atrophy of the small bowel mucosa. The degree of tTG-IgA elevation generally reflects the intensity of ongoing gluten-driven immune activation.
This blood test checks for an antibody your immune system makes when it reacts to gluten, and a positive result is a strong signal that celiac disease may be present. If you have already been diagnosed with celiac disease, this test helps your doctor see whether your gluten-free diet is working.
When elevated: Elevated tTG-IgA, particularly at levels ≥10× the upper limit of normal, is strongly associated with celiac disease and significant small intestinal villous atrophy (Marsh 3 lesions). Persistently elevated levels in a diagnosed patient on a gluten-free diet suggest ongoing gluten exposure, dietary non-adherence, or refractory celiac disease, and warrant further clinical evaluation. Untreated or poorly controlled celiac disease is associated with increased risk of malabsorption, nutritional deficiencies, osteoporosis, and small bowel lymphoma. When low: A low or undetectable tTG-IgA in an IgA-sufficient individual on a gluten-containing diet makes active celiac disease unlikely, though it does not entirely exclude seronegative celiac disease, which occurs in a small minority of biopsy-confirmed cases. In a patient with known celiac disease on a gluten-free diet, normalization of tTG-IgA is a favorable indicator of mucosal recovery and dietary adherence. Very low or absent levels have no independent adverse clinical significance beyond their diagnostic context.
tTG-IgA is not athlete-specific but relevant to active individuals if celiac disease is suspected. Undiagnosed celiac disease can impair nutrient absorption (iron, B12, folate), reduce energy availability, delay recovery, and increase injury risk; screening may help explain persistent fatigue, GI distress during training, or performance plateaus.
Turnaround Time
4 days (up to 6 days)
Method
Enzyme immunoassay (EIA)
Order online
Choose your lab and check out. We send your lab requisition automatically — no doctor visit needed.
Get your sample collected
Visit a lab service center near you for a quick blood draw (or book at-home phlebotomy where available).
See your results
Your results land in your Insider portal, ready to review and act on — that easy.
Your price
$18.00$55
3.1× less than retail
Versus the typical direct-to-consumer retail price for this test (illustrative — consumer prices vary by provider and region).
$18.00
$40.00
$45.00
Peer-reviewed sources supporting the educational content on this page.
Tissue transglutaminase IgA (tTG-IgA) is an autoantibody directed against the enzyme transglutaminase 2, which is the primary autoantigen in celiac disease.
This blood test checks for an antibody your immune system makes when it reacts to gluten, and a positive result is a strong signal that celiac disease may be present. If you have already been diagnosed with celiac disease, this test helps your doctor see whether your gluten-free diet is working.
When elevated: Elevated tTG-IgA, particularly at levels ≥10× the upper limit of normal, is strongly associated with celiac disease and significant small intestinal villous atrophy (Marsh 3 lesions).
The t-Transglutaminase (tTG) IgA test starts at $18.00 at Labcorp, Quest, or BioReference. No doctor's visit and no insurance needed; we do not bill insurance. Fitomics Insider members pay from $13.00.
Results for the t-Transglutaminase (tTG) IgA test are typically ready about 4 days after your draw, and up to 6 days for some samples. Your results land in your Insider portal.
No. When you order the t-Transglutaminase (tTG) IgA test from Fitomics Research Labs, a licensed physician in our 50-state network reviews and signs your requisition after checkout, and it lands in your portal and inbox. Then visit any Labcorp, Quest, or BioReference patient service center for your draw; results post to your Insider portal.
Looking for something else? Browse every test by category.